These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38260317)

  • 1. Heparan sulfate selectively inhibits the collagenase activity of cathepsin K.
    Zhang X; Luo Y; Hao H; Krahn JM; Su G; Dutcher R; Xu Y; Liu J; Pedersen LC; Xu D
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate selectively inhibits the collagenase activity of cathepsin K.
    Zhang X; Luo Y; Hao H; Krahn JM; Su G; Dutcher R; Xu Y; Liu J; Pedersen LC; Xu D
    Matrix Biol; 2024 May; 129():15-28. PubMed ID: 38548090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.
    Zhu G; Chen W; Tang CY; McVicar A; Edwards D; Wang J; McConnell M; Yang S; Li Y; Chang Z; Li YP
    Int J Biol Sci; 2022; 18(14):5522-5538. PubMed ID: 36147479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
    Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
    Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.
    Chen W; Gao B; Hao L; Zhu G; Jules J; MacDougall MJ; Wang J; Han X; Zhou X; Li YP
    J Periodontal Res; 2016 Oct; 51(5):647-60. PubMed ID: 26754272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
    Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
    J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a New Class of Cathepsin K Inhibitors in Rhizoma Drynariae as Potential Candidates for the Treatment of Osteoporosis.
    Qiu ZC; Dong XL; Dai Y; Xiao GK; Wang XL; Wong KC; Wong MS; Yao XS
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999266
    [No Abstract]   [Full Text] [Related]  

  • 9. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
    Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
    Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.
    Pang M; Rodríguez-Gonzalez M; Hernandez M; Recinos CC; Seldeen KL; Troen BR
    J Cell Biochem; 2019 Aug; 120(8):12382-12392. PubMed ID: 30816596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin-K Activity Detection, Revealing Nuclear Activity.
    Dey G; Sinai-Turyansky R; Yakobovich E; Merquiol E; Loboda J; Sridharan N; Houri-Haddad Y; Polak D; Yona S; Turk D; Wald O; Blum G
    Adv Sci (Weinh); 2024 Jul; ():e2401518. PubMed ID: 38970171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
    Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
    Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis.
    Li M; Yang S; Xu D
    J Biol Chem; 2016 Nov; 291(46):24160-24171. PubMed ID: 27697839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells.
    Vashum Y; Kottaiswamy A; Bupesh G; Singh RP; Kalaiselvan P; Thiagarajan K; Samuel S
    Curr Mol Pharmacol; 2021; 14(6):1134-1145. PubMed ID: 33573566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.
    Li Z; Hou WS; Escalante-Torres CR; Gelb BD; Bromme D
    J Biol Chem; 2002 Aug; 277(32):28669-76. PubMed ID: 12039963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
    Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
    Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin K deficiency in mice induces structural and metabolic changes in the central nervous system that are associated with learning and memory deficits.
    Dauth S; Sîrbulescu RF; Jordans S; Rehders M; Avena L; Oswald J; Lerchl A; Saftig P; Brix K
    BMC Neurosci; 2011 Jul; 12():74. PubMed ID: 21794126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
    Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.
    Hao L; Chen J; Zhu Z; Reddy MS; Mountz JD; Chen W; Li YP
    J Periodontol; 2015 Aug; 86(8):972-83. PubMed ID: 25879791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.